Get the latest analysis on Hims & Hers Health, Inc. stock with valuation insights, business risks, and forecasts. Click here ...

Hims & Hers is promoting Chief Commercial Officer Mike Chi to operating chief. Chi will succeed Nader Kabbani as chief operating officer on Nov. 2, the digital healthcare company said. Kabbani plans ...

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark ...

Many investors have fallen in love with Hims & Hers (HIMS) because weight-loss drugs have been a powerful catalyst for this emerging tele-health company’s initial growth. HIMS kept at weight loss ...

The great thing about finding these innovative companies is that you don't have to be first line to buy shares. You could ...

But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our ...

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $56, signifying a -2.95% move from its prior day's close.

Joe Spector, who started two successful companies, says changing his sleep routine led to better business outcomes.

This article was reviewed by Felix Gussone, MD. If you’ve been feeling a bit more couch potato than go-getter lately, ...

Progyny vs. Hims & Hers -- which goes on the watch list? Intel and Nvidia 's big $5 billion deal. Reflections on Rule Breaker investing. To catch full episodes of all The Motley Fool's free podcasts, ...

If you have been eyeing Hims & Hers Health and weighing your next move, you are not alone. After a stunning run that has seen the stock surge 101.9% year-to-date and deliver a jaw-dropping 216.1% ...

HIYY is the newest member of the YieldMax ® ETF family and like all YieldMax ® ETFs, aims to deliver current income to investors. With respect to distributions, HIYY will be a Group D ETF , and its ...